Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Nektar Therapeutics (NKTR)  
$1.27 0.01 (0.79%) as of 4:30 Fri 5/31


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 179,400,000
Market Cap: 227.84(M)
Last Volume: 2,211,986 Avg Vol: 2,301,679
52 Week Range: $0.449 - $1.83
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Delivery

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Nektar Therapeutics is a research-based biopharmaceutical company. Co.'s research and development pipeline of investigational drugs includes potential therapies for cancer and autoimmune disease. Co.'s proprietary programs include: Immuno-oncology, which involves in developing medicines that target biological pathways which stimulate and sustain the body's immune response in order to fight cancer; and Pain, NKTR-181, a mu-opioid analgesic drug candidate patients with chronic low back pain. Co.'s NKTR-358 is an investigational drug designed to correct the underlying immune system imbalance in the body which occurs in patients with autoimmune disease.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 86,265 122,918 235,260 541,068
Total Sell Value $152,594 $177,518 $247,417 $1,284,611
Total People Sold 4 4 7 10
Total Sell Transactions 4 7 16 37
End Date 2024-03-03 2023-12-01 2023-06-02 2022-06-02

   
Records found: 913
  Page 28 of 37  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Nicholson John SVP & Chief Financial Officer   •       –      –    2015-08-12 4 OE $6.46 $584,000 D/D 90,000 141,116     -
   Nicholson John SVP & Chief Financial Officer   •       –      –    2015-08-11 4 OE $6.98 $2,437,100 D/D 295,000 55,092     -
   Nicholson John SVP & Chief Financial Officer   •       –      –    2015-08-11 4 AS $10.67 $2,716,089 D/D (249,908) 10,000     -
   Krivulka Joseph J Director   –       •      –    2015-07-24 4 OE $8.81 $132,150 D/D 15,000 35,000     -
   Labrucherie Gil M SVP & General Counsel   •       –      –    2015-07-14 4 AS $11.78 $392,675 D/D (33,334) 4,251     -
   Labrucherie Gil M SVP & General Counsel   •       –      –    2015-07-14 4 OE $6.98 $232,671 D/D 33,334 37,585     -
   Robin Howard W President & CEO   •       •      –    2015-07-14 4 AS $11.78 $687,175 D/D (58,334) 10,000     -
   Robin Howard W President & CEO   •       •      –    2015-07-14 4 OE $6.98 $407,171 D/D 58,334 68,334     -
   Wang Susan Director   –       •      –    2015-06-29 4 AS $12.70 $381,000 D/D (30,000) 20,000     -
   Wang Susan Director   –       •      –    2015-06-29 4 OE $5.15 $209,400 D/D 30,000 35,000     -
   Chess Robert Director   –       •      –    2015-06-19 4 AS $11.81 $177,150 D/D (15,000) 260,623     -
   Chess Robert Director   –       •      –    2015-06-19 4 OE $8.81 $132,150 D/D 15,000 275,623     -
   Lingnau Lutz Director   –       •      –    2015-06-15 4 AS $11.15 $278,750 D/D (25,000) 16,450     -
   Lingnau Lutz Director   –       •      –    2015-06-15 4 OE $6.65 $166,250 D/D 25,000 41,450     -
   Kuebler Christopher A Director   –       •      –    2015-01-13 4 AS $16.00 $240,000 D/D (15,000) 20,000     -
   Kuebler Christopher A Director   –       •      –    2015-01-13 4 OE $8.81 $132,150 D/D 15,000 35,000     -
   Chess Robert Director   –       •      –    2014-12-29 4 AS $15.34 $452,530 D/D (29,500) 260,623     -
   Chess Robert Director   –       •      –    2014-12-29 4 OE $15.24 $449,580 D/D 29,500 290,123     -
   Thomsen Jillian B. SVP & Chief Accounting Officer   •       –      –    2014-12-22 4 AS $15.56 $77,800 D/D (5,000) 2,999     -
   Thomsen Jillian B. SVP & Chief Accounting Officer   •       –      –    2014-12-22 4 OE $11.38 $56,900 D/D 5,000 7,999     -
   Labrucherie Gil M SVP & General Counsel   •       –      –    2014-12-01 4 AS $17.00 $510,000 D/D (30,000) 4,251     -
   Labrucherie Gil M SVP & General Counsel   •       –      –    2014-12-01 4 OE $4.65 $139,500 D/D 30,000 34,251     -
   Robin Howard W President & CEO   •       •      –    2014-12-01 4 AS $17.00 $3,553,952 D/D (209,056) 10,000     -
   Robin Howard W President & CEO   •       •      –    2014-12-01 4 OE $6.98 $1,459,211 D/D 209,056 219,056     -
   Labrucherie Gil M SVP & General Counsel   •       –      –    2014-11-28 4 AS $17.02 $1,531,800 D/D (90,000) 4,251     -
  913 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 28 of 37
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us